Hong Kong, 20 March 2025 — AUISET was pleased to take part in the IHIT Webinar co-hosted with the Hong Kong Science and Technology Parks Corporation (HKSTP), a forward-looking event aimed at advancing Smart Care initiatives within the healthcare ecosystem.
During the session, AUISET presented insights on Aggregation-Induced Emission (AIE) fluorescence technology, a promising frontier in biomedical imaging and diagnostics. In addition, we introduced our top-tier diagnostic product — CHI3L1 (Chitinase 3-like Protein 1) Rapid Antigen Test (RAT) kits — designed to enable early detection of liver fibrosis, a critical need in preventive healthcare.
The webinar engaged more than 200 staff members from the Hospital Authority (HA), underscoring a strong interest in innovative tools for early-stage disease diagnosis and precision medicine.
As a biotech innovator, AUISET continues to commit to delivering cutting-edge, accessible, and effective diagnostic solutions to meet global healthcare challenges.
